Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

353
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
353
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

299
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
299
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

622
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
622
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

427
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
427
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

239
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
239
Difference from Background: Limit of Detection01:05

Difference from Background: Limit of Detection

8.6K
The limit of detection (LOD) is the smallest amount of analyte that can be distinguished from the background noise. The LOD value corresponds to the concentration at which the analyte signal is three times larger than the standard deviation of the blank signal. Below this value, the analyte signal cannot be differentiated from the background noise. It is calculated by dividing the calibration slope by 3 times the standard deviation of the blank signals.
The LOD indicates the presence or absence...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic impact of low BMI on outcomes following definitive radiotherapy for esophageal squamous cell carcinoma.

Frontiers in nutrition·2026
Same author

Antibiotic exposure and cancer risk: an umbrella review elucidating the direction of risk across 14 malignancies.

Journal of public health (Oxford, England)·2026
Same author

Joint Estimation of Coherent Signal DOA and Polarization Parameters Based on Improved BSBL.

Sensors (Basel, Switzerland)·2026
Same author

Inflammatory Signaling and Emotional Symptoms in Hashimoto's Thyroiditis Beyond Thyroid Function Status.

Neuroendocrinology·2026
Same author

CbLTP67 Negatively Regulates Salt Tolerance by Interaction With CbPAT12 and CbRD19A to Disrupt Salicylic Acid-Mediated Stomatal Closure in Catalpa bungei.

Plant, cell & environment·2026
Same author

Colossal Photovoltaic Current in Ferroelectric Oxide by Constructing Defect Band.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

A Bayesian phase I/II platform design with data augmentation accounting for delayed outcomes.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Apr 21, 2026

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.1K

Minimum clinically important difference in medical studies.

A S Hedayat1, Junhui Wang2, Tu Xu3

  • 1Department of Mathematics, Statistics, and Computer Science, University of Illinois at Chicago, Chicago, Illinois 60607, U.S.A.

Biometrics
|October 21, 2014
PubMed
Summary
This summary is machine-generated.

This study introduces a novel framework for estimating the minimum clinically important difference (MCID) using diagnostic measurements and patient-reported outcomes (PROs). The method offers improved accuracy and personalized thresholds for clinical trial analysis.

Keywords:
Fisher consistencyMargin classificationMinimum clinically important differenceNon-convex minimizationSupport vector machine

More Related Videos

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

2.0K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.1K

Related Experiment Videos

Last Updated: Apr 21, 2026

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.1K
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

2.0K
Minimal Erythema Dose MED Testing
06:24

Minimal Erythema Dose MED Testing

Published on: May 28, 2013

42.1K

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Health Outcomes Research

Background:

  • Minimum clinically important difference (MCID) is a crucial tool in clinical trials for interpreting treatment effects.
  • Existing MCID estimation methods often lack robust theoretical justification.
  • There is a need for advanced methods that integrate diverse data sources for MCID estimation.

Purpose of the Study:

  • To propose a novel, theoretically grounded framework for estimating MCID.
  • To incorporate both diagnostic measurements and patient-reported outcomes (PROs) into MCID estimation.
  • To extend MCID estimation from population-level to personalized thresholds.

Main Methods:

  • Formulating population-based MCID as a large margin classification problem.
  • Extending the framework to personalized MCID for individualized thresholding.
  • Establishing asymptotic consistency and finite-sample prediction accuracy bounds.

Main Results:

  • The proposed framework demonstrates theoretical consistency and provides prediction accuracy bounds.
  • Simulations and analyses of two Phase-3 clinical trials show the method's advantages.
  • The framework effectively integrates diagnostic and PRO data for robust MCID estimation.

Conclusions:

  • The novel framework offers a theoretically sound and practically advantageous approach to MCID estimation.
  • Personalized MCID estimation can enhance the interpretation of treatment effects in clinical trials.
  • This method advances statistical inference tools for clinical research by leveraging multi-source data.